Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$3.89 - $20.97 $77,473 - $417,638
19,916 Added 194.78%
30,141 $381,000
Q1 2024

May 15, 2024

BUY
$3.76 - $6.02 $38,446 - $61,554
10,225 New
10,225 $48,000
Q4 2022

Feb 14, 2023

BUY
$8.86 - $25.04 $96,627 - $273,086
10,906 New
10,906 $112,000
Q4 2020

Feb 12, 2021

SELL
$78.74 - $139.5 $157,480 - $279,000
-2,000 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$79.44 - $178.51 $158,880 - $357,020
2,000 New
2,000 $217,000

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $670M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Alpine Global Management, LLC Portfolio

Follow Alpine Global Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpine Global Management, LLC with notifications on news.